Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase -: Implications for polymerase translocation and drug resistance

被引:80
|
作者
Marchand, B
Götte, M
机构
[1] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2T5, Canada
[3] McGill Univ, Dept Expt Med, Montreal, PQ H3A 2T5, Canada
关键词
D O I
10.1074/jbc.M304262200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to nucleoside analogue inhibitors of the reverse transcriptase of the HIV-1 often involves phosphorolytic excision of the incorporated chain terminator. Previous crystallographic and modeling studies suggested that this reaction could only occur when the enzyme resides in a pre-translocational stage. Here we studied mechanisms of polymerase translocation using novel site-specific footprinting techniques. Classical footprinting approaches, based on the detection of protected nucleic acid residues, are not sensitive enough to visualize subtle structural differences at single nucleotide resolution. Thus, we developed chemical footprinting techniques that give rise to hyperreactive cleavage on the template strand mediated through specific contacts with the enzyme. Two specific cuts served as markers that defined the position of the polymerase and RNase H domain, respectively. We show that the presence of the next correct dNTP, following the incorporated chain terminator, caused a shift in the position of the two cuts a single nucleotide further downstream. The footprints point to monotonic sliding motions and provide compelling evidence for the existence of an equilibrium between pre- and post-translocational stages. Our data show that enzyme translocation is reversible and uncoupled from nucleotide incorporation and the release of pyrophosphate. This translocational equilibrium ensures access to the pre- translocational stage after incorporation of the chain terminator. The efficiency of excision correlates with an increase in the population of complexes that exist in the pre- translocational stage, and we show that the latter configuration is preferred with an enzyme that contains mutations associated with resistance to nucleoside analogue inhibitors.
引用
收藏
页码:35362 / 35372
页数:11
相关论文
共 50 条
  • [31] Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation
    Popov, S
    Dubrovsky, L
    Lee, MA
    Pennathur, S
    Haffar, O
    AlAbed, Y
    Tonge, P
    Ulrich, P
    Rexach, M
    Blobel, G
    Cerami, A
    Bukrinsky, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11859 - 11864
  • [32] Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors
    Asahchop, Eugene L.
    Wainberg, Mark A.
    Sloan, Richard D.
    Tremblay, Cecile L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (10) : 5000 - 5008
  • [33] Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors
    Sugiura, W
    Matsuda, M
    Matsuda, Z
    Abumi, H
    Okano, A
    Oishi, T
    Moriya, K
    Yamamoto, T
    Fukutake, K
    Mimaya, J
    Ajisawa, A
    Taki, M
    Yamada, K
    Nagai, Y
    JOURNAL OF HUMAN VIROLOGY, 1999, 2 (03) : 146 - 153
  • [34] Phenotypic drug resistance patterns in subtype a HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations
    Eshleman, SH
    Jones, D
    Galovich, J
    Paxinos, EE
    Petropoulos, CJ
    Jackson, JB
    Parkin, N
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 289 - 293
  • [35] Molecular Characterization of Ambiguous Mutations in HIV-1 Polymerase Gene: Implications for Monitoring HIV Infection Status and Drug Resistance
    Zheng, Du-Ping
    Rodrigues, Margarida
    Bile, Ebi
    Nguyen, Duc B.
    Diallo, Karidia
    DeVos, Joshua R.
    Nkengasong, John N.
    Yang, Chunfu
    PLOS ONE, 2013, 8 (10):
  • [36] Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
    Michailidis, Eleftherios
    Marchand, Bruno
    Kodama, Eiichi N.
    Singh, Kamlendra
    Matsuoka, Masao
    Kirby, Karen A.
    Ryan, Emily M.
    Sawani, Ali M.
    Nagy, Eva
    Ashida, Noriyuki
    Mitsuya, Hiroaki
    Parniak, Michael A.
    Sarafianos, Stefan G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (51) : 35681 - 35691
  • [37] Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site-specific photocross-linking
    Rausch, JW
    Sathyanarayana, BK
    Bona, MK
    Le Grice, SFJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) : 16015 - 16022
  • [38] Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S - Template interactions influence substrate recognition at the polymerase active site
    Klarmann, GJ
    Smith, RA
    Schinazi, RF
    North, TW
    Preston, BD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) : 359 - 366
  • [39] The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
    Garforth, Scott J.
    Lwatula, Chisanga
    Prasad, Vinayaka R.
    VIRUSES-BASEL, 2014, 6 (10): : 4080 - 4094
  • [40] Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
    Mark J. Siedner
    Michelle A. Moorhouse
    Bryony Simmons
    Tulio de Oliveira
    Richard Lessells
    Jennifer Giandhari
    Stephen A. Kemp
    Benjamin Chimukangara
    Godspower Akpomiemie
    Celicia M. Serenata
    Willem D. F. Venter
    Andrew Hill
    Ravindra K. Gupta
    Nature Communications, 11